---
company: Outlook Therapeutics, Inc.
ticker: OTLK
form: 8-K
filed: 2026-05-13
accession: 0001104659-26-060305
source: https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/
---

# Outlook Therapeutics (OTLK) earnings release, May 13, 2026

Outlook Therapeutics, Inc. (OTLK) · Form 8-K, Item 2.02 · Filed 2026-05-13 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/)

No press release attached to this 8-K.
